Medtronic, Stryker and B. Braun Melsungen AG are dominating the Global Minimally Invasive Surgery Market in 2021.

Global Minimally Invasive Surgery Market is expected to grow with the CAGR of 8.3% in the forecast period of 2021 to 2028. The years considered for study are as mentioned below.

 Access Full Report @ https://www.databridgemarketresearch.com/reports/global-minimally-invasive-surgery-market

Global minimally invasive surgery market is a highly consolidated market, which includes specific number of key players. The market has witnessed increased strategic developments owing to favourable market scenario.    

The major players dealing in global minimally invasive surgery market are introducing strong range of products provider along with launching new products and adopting strategic initiative such as acquisition, agreement into the market. This helped companies to maximize the sales with enhanced product portfolio.

For instance,

  • In February 2020, Intuitive Surgical, announced it had acquired privately-held Orpheus Medical to deepen and expand its integrated informatics platform. This acquisition by the company has increased its credibility in the market, leading to increased demand for the company's product.

Medtronic is the dominating player in global minimally invasive surgery market. The other key players existing in the market includes Stryker, CONMED Corporation, Intuitive Surgical, NuVasive, Inc., Fortimedix Surgical, Microline Surgical, Cirtec, OmniGuide Holdings, Inc., Arthrex, Inc., Eximis Surgical, Inc., B. Braun Melsungen AG, Medtronic, Johnson & Johnson Services, Inc., Abbott, Zimmer Biomet, Smith & Nephew, Applied Medical Resources Corporation, Silex Medical, LLC, Freudenberg Medical, and BEMA MEDICAL among others.

Minimally Invasive Surgery Market

Medtronic

Medtronic was founded in 1949 and is headquartered Minneapolis, U.S. The company engages development, manufacture, distribution and sale of medical devices and services. The company is providing products under advanced surgical technologies, cardiac rhythm, cardiovascular, diabetes, digestive & gastrointestinal, ear, nose & throat, general surgery, gynaecology, neurology, oral & maxillofacial, patient monitoring, renal care, respiratory, spinal & orthopaedic, surgical navigation & imaging, urological, product manual, product performance and advisories. The market focus products lie under proactivmd 3-piece system, proactiv solution 3-step system, proactiv+ 3-step system product category.  

For instance,

  • In May 2020, Medtronic announced the launch of new paediatric monitor SonarMed which will alert clinicians to potential airway obstruction during ventilation. This will help the clinician providing vital information required and help the company to increase its sales.

 The company has wide presence across Americas, Europe, Middle East and Africa, and Asia-Pacific. The company also has various subsidiary companies such as Medtronic of Canada Ltd. (Canada), Mazor Robotics (Israel), HeartWare International Inc. (U.S.), Titan Spine, Inc. (U.S.), and Given Imaging (Israel) among others.

Stryker

Stryker was incorporated in 1946 and is headquartered in Michigan, U.S. The company deals in the offering innovative products and services in orthopaedics, medical and surgical, and neurotechnology and spine that help improve patients and hospital outcomes. The business segment includes medical and surgical (medsurg), neurotechnology and spine and orthopaedics. The focused business segment includes medical and surgical (medsurg).  The company is providing products under medical & surgical equipment, orthopaedics, neurotechnology and services. The market focus products lie under medical & surgical equipment product category. The company has initiated many strategic initiatives to expand its market.

For instance,

  • In November 2020, Stryker announced that it has acquired the Wright Medical Group N.V., a medical devices company focused on extremities and biologics across the globe. This acquisition done by the company has increased the product portfolio of the company leading to increased sales and demand for its products in future.

The company has wide presence across Americas, Asia-Pacific, Middle East and Africa and Europe. The company also has various subsidiary companies such as Aimago SA (Switzerland), Berchtold + Fritz GmbH (Germany), Jiangsu Chuangyi Medical Instrument Company Limited (China), Pficonprod Pty. Ltd. (Australia) and P.C. Sweden Holding AB (Sweden) among others.

B, Braun Melsungen AG

B. Braun Melsungen AG was incorporated in 1893 and is headquartered in 1893. The company engaged focuses on production and marketing of systems for anesthesia, intensive care, cardiology and surgery among others. The company is engaged in providing brands in categories like abdominal surgery, diabetes care, infusion therapy, nutrition therapy, ostomy care, wound management, cardio-thoracic surgery, extracorporeal blood treatment, interventional vascular therapy, orthopaedic surgery, spine surgery, continence care & urology, infection prevention, neurosurgery, pain therapy & sterile goods management among which abdominal surgery, cardio-thoracic surgery, orthopaedic surgery, spine surgery are the market focused category.

  • In July 2019, B. Braun Melsungen AG announced that it had acquired the Nephtec company. This acquisition will help the company to increase its product portfolio in the segment of extracorporeal blood treatment.

The company has wide presence across Americas, Europe, Asia-Pacific, and Middle East and Africa The company has various subsidiary companies such as B. Braun Medical (Pty) Limited (South Africa), B. Braun Medical Gulf Kenya Ltd. (Kenya), B. Braun Medical Gulf Kenya Ltd. (Zambia), B. Braun Aesculap Japan Co., Ltd. (Japan), and B. Braun Singapore Pte Ltd. (Singapore) among others. The company has initiated many strategic initiatives to expand its market.